O. Kalau

EVERSANA Value & Evidence Division

Author Of 1 Presentation

Patient-Reported Outcomes and Quality of Life Poster Presentation

P1048 - Quality of life and economic burden of fatigue in people with multiple sclerosis: a systematic literature review (ID 1337)

Speakers
Presentation Number
P1048
Presentation Topic
Patient-Reported Outcomes and Quality of Life

Abstract

Background

Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and irreversible disability. Fatigue is one of the most common MS-related symptoms and is characterized by a persistent lack of energy that impairs daily functioning. The burden of MS-related fatigue is complex and multidimensional, and to our knowledge, no systematic literature review has been conducted on this subject.

Objectives

To conduct a systematic literature review identifying published data on the quality of life (QoL) and economic burden of fatigue in people with MS.

Methods

Systematic searches were conducted in MEDLINE, Embase, and Evidence-Based Medicine Reviews to identify published studies quantifying the burden of fatigue on QoL and economic outcomes in people with relapsing-remitting MS, secondary progressive MS, and clinically isolated syndrome. English-language articles published from 2010 to January 2020 were included. Studies reporting comparisons between fatigued and non-fatigued people with MS were prioritized as they were most interpretable for understanding the burden of fatigue in MS. Studies assessing associations between outcomes and fatigue as a continuous measure were included to supplement the available data on economic burden due to gaps in the literature.

Results

In the systematic search, 8,147 unique records were identified, of which 19 records met the inclusion criteria. Of the included records comparing fatigued to non-fatigued people with MS, 11 reported QoL outcomes and 9 reported economic outcomes. The supplementary screen for economic studies with fatigue as a continuous measure included 20 records.

The presence of MS-related fatigue was associated with significantly lower QoL on one or more validated scales or subscales in each reviewed QoL study. Results on the economic impact of fatigue were more heterogeneous, but most studies reported a significant association between presence or severity of fatigue and employment status, capacity to work, and sick leave. There is a gap in evidence regarding the direct costs of MS-related fatigue and the financial or QoL burden placed on the caregivers of affected people.

Conclusions

MS-related fatigue is associated with considerable QoL and economic burden. Further studies are needed to better understand the impact of fatigue on direct costs for people with MS and their caregivers.

Collapse